Drug Delivery CDMO
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,814
NCT02232087
Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2014
Completion: Dec 31, 2014
NCT03015259
Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
Phase: Phase 3
Start: Dec 29, 2016
Completion: Feb 8, 2018
Loading map...